tert-butylhydroperoxide has been researched along with azacitidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohta, T; Watanabe-Akanuma, M; Yamagata, H | 1 |
| Bogachek, M; Cyr, AR; Domann, FE; Kulak, MV; Li, T; Price, DH; Spanheimer, PM; Weigel, RJ; Woodfield, GW | 1 |
2 other study(ies) available for tert-butylhydroperoxide and azacitidine
| Article | Year |
|---|---|
A comparison of mutation spectra detected by the Escherichia coli lac(+) reversion assay and the Salmonella typhimurium his(+) reversion assay.
Topics: 2-Aminopurine; 4-Nitroquinoline-1-oxide; Alkylating Agents; Azacitidine; Benzene Derivatives; Cytidine; DNA; DNA Mutational Analysis; Dose-Response Relationship, Drug; Escherichia coli; Ethylnitrosourea; Formaldehyde; Furans; Furylfuramide; Glyoxal; Histidine; Lac Operon; Methylnitronitrosoguanidine; Mutagenicity Tests; Mutagens; Oxidants; Phosmet; Plasmids; Point Mutation; Salmonella typhimurium; Sodium Azide; tert-Butylhydroperoxide; Uracil | 2000 |
Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
Topics: Azacitidine; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; CpG Islands; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; MCF-7 Cells; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sequence Analysis, DNA; tert-Butylhydroperoxide; Transcription Factor AP-2; Transcription, Genetic | 2013 |